Wikidata

(Q45237759)

English

The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation

scientific article published in January 2005

In more languages

Statements

title
The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15669884
retrieved
11 December 2017
author name string
Jose de Leon
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15669884
retrieved
11 December 2017
Margaret T Susce
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15669884
retrieved
11 December 2017
Run-Mei Pan
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15669884
retrieved
11 December 2017
Maureen Fairchild
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15669884
retrieved
11 December 2017
Walter H Koch
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15669884
retrieved
11 December 2017
Peter J Wedlund
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15669884
retrieved
11 December 2017
publication date
1 January 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
15669884
retrieved
11 December 2017
page(s)
15-27
1 reference
stated in
Europe PubMed Central
PubMed ID
15669884
retrieved
11 December 2017

Identifiers

DOI
10.4088/JCP.V66N0103
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45237759&oldid=2070951916"